This article is more than 5 years old. Information may no longer be current.
Memorial Sloan Kettering society presents inaugural prize
Click Here to Manage Email Alerts
Richard J. O’Reilly, MD, of Memorial Sloan Kettering Cancer Center has been named the inaugural recipient of The Society of Memorial Sloan Kettering Prize.
The award recognizes a person who made outstanding contributions made to the field of pediatric oncology.
Richard J. O’Reilly,
“For nearly 50 years, Richard O’Reilly has built an influential body of work that has advanced pediatric oncology,” Craig Thompson, MD, president and CEO of Memorial Sloan Kettering Cancer Center, said in a press release.
O’Reilly, chairman of the department of pediatrics and director of the bone marrow transplantation program at Memorial Sloan Kettering, has helped pioneer the development of curative marrow transplantation approaches for patients who lack HLA-matched siblings.
“I am very honored to be recognized as the inaugural recipient of this award,” O’Reilly said in a press release. “To have the satisfaction of knowing that your work has contributed to the lives of children and their families is impossible to put into words. I am grateful to The Society of Memorial Sloan Kettering for their unwavering support and partnership. This global award heightens awareness of the field of pediatric oncology and, in particular, the enormous contributions made in our efforts to control and cure childhood cancers.”
The Society of Memorial Sloan Kettering is a volunteer-led organization dedicated to promoting the well-being of patients, supporting cancer research, and providing education on the early prevention, detection and treatment of cancer.